Divestiture

A report on 69,000 jobs shows Londoners outsource hedge trimming most. The real villain? Ladders, waste removal, and tight urban spaces.

A Florida jury found Publix 100% liable for a fall that led to three spinal surgeries for a young mother, rejecting the company's $600k offer.

Alloy producer Afarak's profits plummet despite rising revenue, revealing the harsh realities of currency woes, cheap imports, and a stalled market.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.

The junior miner sheds non-core assets to double down on its high-grade Mexican silver project while upgrading to a top-tier U.S. market.

Singapore's OUE REIT makes a strategic A$357M entry into Australia, acquiring a stake in Sydney's prime, green-certified Salesforce Tower.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

Industrial packaging giant Greif rewards shareholders, but a closer look at its finances and dual-class stock reveals a company in major transition.

As corporate dentistry grows, one Ann Arbor practice's shift to woman-owned leadership highlights a demand for personalized, health-focused cosmetic care.

Over 1,000 professionals are in Chicago for the NeighborWorks Training Institute, bringing a $5.2M economic boost and new strategies for the housing crisis.

With vet emergencies costing thousands, a new AKC initiative provides a lifeline to low-income owners facing impossible financial decisions.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

A 94% surge in water damage claims reveals a growing crisis, yet a new survey shows over half of Canadians plan no action to protect their homes.

Vantage Towers and Gridle partner to transform mobile sites into smart energy hubs, boosting resilience, profits, and sustainability. Here's how.

A landmark Supreme Court decision opens the door for massive tariff refunds. New AI platforms are helping companies quickly navigate the complex claims process.

The FDA is reviewing a new, more affordable alternative to the costly arthritis drug Orencia, potentially saving patients and the healthcare system billions.